Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
Steady Dividend Plays: 3 Aristocrat Stocks to Own Now
01:37pm, Monday, 06'th May 2024
On Wall Street, many income-focused investors prioritize long-term stability and reliability over short-term volatility. Enter the Dividend Aristocrat stocks.
ChatGPT picks 3 stocks to buy and hold forever
04:59am, Monday, 06'th May 2024
It is often said that trying to beat the stock market by perfecting the timing of each trade is far more trouble than it is worth and could lead to far worse results than making strong picks and just
Buy 1 Dog Of The Dow In May; See 4 More Play
08:56am, Sunday, 05'th May 2024
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.�
5 Relatively Secure And Cheap Dividend Stocks To Invest In - May 2024
09:00am, Saturday, 04'th May 2024
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 03'rd May 2024
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
3 Dividend Growth Stocks that Just Raised Their Payouts
08:30am, Friday, 03'rd May 2024
Dividend increases can usually be a sign of financial health -- but not always. In some cases, companies raise their payouts simply for the sake of extending a streak.
5 Expected Dividend Increases In May 2024
01:38am, Friday, 03'rd May 2024
5 Expected Dividend Increases In May 2024
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
03:57pm, Wednesday, 01'st May 2024
Healthcare stocks certainly haven't set the world on fire lately. The S&P Health Care Index is up 3% so far in 2024 compared to an 8% gain in the benchmark S&P 500.
JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits
11:26am, Wednesday, 01'st May 2024
Johnson & Johnson (NYSE: JNJ ) stock is a hot topic on Wednesday after the company proposed a $6.5 billion settlement over talc cancer lawsuits. Johnson & Johnson is seeking to bankrupt LTL Management
Johnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in US
10:15am, Wednesday, 01'st May 2024
Through a bankruptcy filing of its subsidiary company, J&J will be able to resolve about 99.75% of the pending talc lawsuits against the company and its affiliates in the U.S.
Johnson & Johnson Proposes Nearly $6.5B Package to Settle Talc Ovarian Cancer Suits
09:55am, Wednesday, 01'st May 2024
Johnson & Johnson (JNJ) shares rose in early trading Wednesday after the company announced a plan that would resolve nearly all pending litigation over claims that its talc powder caused ovarian cance
Johnson & Johnson proposes $6.475 billion settlement in talc lawsuits
08:45am, Wednesday, 01'st May 2024
Johnson & Johnson (JNJ.N) announced on Wednesday a significant move towards resolving ongoing litigation over its baby powder and other talc products, with a proposed settlement amounting to $6.475 bi
Johnson & Johnson unveils latest plan to settle ovarian cancer talc claims
06:52am, Wednesday, 01'st May 2024
Johnson & Johnson JNJ, -1.52% unveiled its latest plan to settle ovarian cancer talc claims with the news of a consensual “prepackaged” reorganization of its LTL Management LLC unit, which manages
J&J advances $6.475 billion settlement of talc cancer lawsuits
06:34am, Wednesday, 01'st May 2024
Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
06:31am, Wednesday, 01'st May 2024
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
